<DOC>
	<DOCNO>NCT01147237</DOCNO>
	<brief_summary>The utilization everolimus-eluting coronary stent coronary artery disease effective reduce repeat revascularization major adverse cardiac event within two year follow-up . To evaluate procedural , short long term clinical outcome multiple everolimus-eluting coronary stent implantation long ( &gt; 30mm ) coronary lesion .</brief_summary>
	<brief_title>Xience/Promus Long Coronary Lesion Registry</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Age â‰¥20 year able undergo CABG 2 . Females pregnant 3 . Patients present angina symptoms myocardial ischemia 4 . Patients available postprocedural observation coronary angiography 24 month 5 . Patients sign patient inform consent 6 . Lesion length 30mm 7 . De novo lesion nonstented restenosed lesion 1 . Patients contraindicate antiplatelet therapy anticoagulant therapy 2 . Patients significant allergic reaction contrast medium 3 . Chronic total occlusion 4 . Lesion TIMI0 5 . Patients chronic renal failure ( SCr &gt; 3.0mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>